Serum and plasma M(r) 92,000 progelatinase levels correlate with spontaneous metastasis of rat 13762NF mammary adenocarcinoma.

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Cancer Research

• Publication date

  1993-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8242639
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer.

  1993cited by this paper
• Mr 92,000 Type IV Collagenase Is Increased in Plasma of Patients with Colon Cancer and Breast Cancer

  1993cited by this paper
• Immunoassay of type IV collagenase/gelatinase (MMP-2) in human plasma.

  1992cited by this paper
• Correlation of serum metalloproteinase levels with lung cancer metastasis and response to therapy.

  1992cited by this paper
• Biological and clinical significance of cathepsin D in breast cancer.

  1992cited by this paper
• The role of cathepsin L in malignant transformation.

  1990cited by this paper
• Stromelysin/transin and tumor progression.

  1990cited by this paper
• Transforming growth factor beta stimulates mammary adenocarcinoma cell invasion and metastatic potential.

  1990cited by this paper
• Urokinase-dependent cell surface proteolysis and cancer.

  1990cited by this paper
• Mr 92,000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells.

  1990cited by this paper
• Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells.

  1990cited by this paper
• Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue.

  1990cited by this paper
• The role of cathepsin L in malignant transformation.

  1990cited by this paper
• Metalloproteinases and cancer invasion.

  1990influential reference
• Cathepsin B and cystatins: evidence for a role in cancer progression.

  1990cited by this paper
• Metastatic tumor cell interactions with endothelium, basement membrane and tissue.

  1989cited by this paper
• SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages.

  1989cited by this paper
• Adhesive and degradative properties of human placental cytotrophoblast cells in vitro

  1989cited by this paper
• Characterization of gelatinase from pig polymorphonuclear leucocytes. A metalloproteinase resembling tumour type IV collagenase.

  1989cited by this paper
• Inhibition by retinoic acid of type IV collagenolysis and invasion through reconstituted basement membrane by metastatic rat mammary adenocarcinoma cells.

  1989cited by this paper
• Independent regulation of collagenase, 72-kDa progelatinase, and metalloendoproteinase inhibitor expression in human fibroblasts by transforming growth factor-beta.

  1989cited by this paper
• Human gelatinase/type IV procollagenase is a regular plasma component

  1989cited by this paper
• Ras oncogene mediated induction of a 92 kDa metalloproteinase; strong correlation with the malignant phenotype.

  1988influential reference
• Influence of organ environment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice.

  1988cited by this paper
• Gelatinases of metastatic cell lines of murine colonic carcinoma as detected by substrate-gel electrophoresis.

  1988cited by this paper
• H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen.

  1988cited by this paper
• Expression of a metalloproteinase that degrades native type V collagen and denatured collagens by cultured human alveolar macrophages.

  1987cited by this paper
• Proteolytic degradation of extracellular matrix in tumor invasion.

  1987cited by this paper
• Degradation of basement membrane type IV collagen and lung subendothelial matrix by rat mammary adenocarcinoma cell clones of differing metastatic potentials.

  1987cited by this paper
• Basement membrane degradative enzymes as possible markers of tumor metastasis.

  1986cited by this paper
• Secretion of metalloproteinases by stimulated capillary endothelial cells. II. Expression of collagenase and stromelysin activities is regulated by endogenous inhibitors.

  1986cited by this paper
• Transient expression of type IV collagenolytic metalloproteinase by human mononuclear phagocytes.

  1986cited by this paper
• Biochemical and immunological characterization of the secreted forms of human neutrophil gelatinase.

  1985cited by this paper
• Comparison of 'spontaneous' and 'experimental' metastasis using rat 13762 mammary adenocarcinoma metastatic cell clones.

  1983cited by this paper
• Purification and characterization of a murine basement membrane collagen-degrading enzyme secreted by metastatic tumor cells.

  1983cited by this paper
• Development and biologic properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma.

  1982cited by this paper

• Prognostic value of different forms of serum MMP-2 and MMP-9 in dogs with mammary tumors; a longitudinal study.

  2023cites this paper
• Repurposing of Antimicrobial Agents for Cancer Therapy: What Do We Know?

  2021cites this paper
• Evaluation of Prognostic Value of Serum Matrix Metalloproteinases (MMP)-2 and MMP-9 in Canine Mammary Gland Tumors; A Longitudinal Study

  2021cites this paper
• Understanding the complexity of the matrix metalloproteinase system and its relevance to age-related diseases: Age-related macular degeneration and Alzheimer's disease.

  2020cites this paper
• NOVEL PATHOPHYSIOLOGICAL FACTORS AND DIAGNOSTIC MARKER IN ORGANIC AND FUNCTIONAL BOWEL DISORDERS Ph.D. thesis

  2020cites this paper
• In Vitro Analysis of Bacosine as Novel Therapeutic Agent for Murine Breast Cancer

  2019cites this paper
• Apoptotic and Nonapoptotic Activities of Pterostilbene against Cancer

  2018cites this paper
• Influence of Hormone Receptor Status on Spinal Metastatic Lesions in Breast Cancer Patients

  2017cites this paper
• Influence of Hormone Receptor Status on Spinal Metastatic Lesions in Patients with Breast Cancer.

  2016cites this paper
• Repurposing Drugs in Oncology (ReDO)—clarithromycin as an anti-cancer agent

  2015cites this paper
• Roles of Matrix Metalloproteinase-9 in Cancer Metastasis

  2014cites this paper
• Role of secreted type I collagen derived from stromal cells in two breast cancer cell lines

  2014cites this paper
• Fecal MMP-9: A New Noninvasive Differential Diagnostic and Activity Marker in Ulcerative Colitis

  2013cites this paper
• Evaluation of Apoptotic Marker Bcl2, CD4+, Human Hepatocyte Growth Factor and Metalloproteinase-9 as Tumor Markers for Patients with Hepatocellular Carcinoma

  2013cites this paper
• Silibinin inhibits TPA-induced cell migration and MMP-9 expression in thyroid and breast cancer cells.

  2013cites this paper
• Effect of TRPV2 cation channels on the proliferation, migration and invasion of 5637 bladder cancer cells

  2013cites this paper
• Smad7 acts as a negative regulator of the epidermal growth factor (EGF) signaling pathway in breast cancer cells.

  2012cites this paper
• Higher risk of matrix metalloproteinase (MMP‐2, 7, 9) and tissue inhibitor of metalloproteinase (TIMP‐2) genetic variants to gallbladder cancer

  2012cites this paper
• Fluorescence detection of MMP-9. I. MMP-9 selectively cleaves Lys-Gly-Pro-Arg-Ser-Leu-Ser-Gly-Lys peptide.

  2011cites this paper
• Microsurgical anatomy of membranous layers of the pituitary gland and the expression of extracellular matrix collagenous proteins

  2011cites this paper
• Late SV40 Factor (LSF) Enhances Angiogenesis by Transcriptionally Up-regulating Matrix Metalloproteinase-9 (MMP-9)*

  2011cites this paper
• The role of genetic factors in breast cancer aetiology

  2010cites this paper
• Profiling of matrix metalloproteinases and tissue inhibitors of metalloproteinases proteins in bladder urothelial carcinoma.

  2010cites this paper
• [Proteases in cancer progression].

  2009cites this paper
• Las proteasas en la progresión neoplásica

  2009cites this paper
• Étude de l'activité anti-cancéreuse du PCK3145, un peptide dérivé de PSP-94, sur les cancers hématologiques

  2009cites this paper
• EGF-induced MMP-9 expression is mediated by the JAK3/ERK pathway, but not by the JAK3/STAT-3 pathway in a SKBR3 breast cancer cell line.

  2009cites this paper
• The Regulatory Role Of Matrix Metalloproteinases In T Cell Activation

  2009cites this paper
• Condicionantes epidemiológicos de salud y su relación con rendimiento escolar en el primer año de la carrera de medicina

  2009cites this paper
• Development of monoclonal antibodies for the identification of novel invasion associated targets in human cancer.

  2008cites this paper
• Human breast adenocarcinoma (MDA-231) and human lung squamous cell carcinoma (Hara) do not have the ability to cause bone resorption by themselves during the establishment of bone metastasis

  2008cites this paper
• Tumor-Specific Urinary Matrix Metalloproteinase Fingerprinting: Identification of High Molecular Weight Urinary Matrix Metalloproteinase Species

  2008cites this paper
• Polyphenols prevent cell shedding from mouse mammary cancer spheroids and inhibit cancer cell invasion in confrontation cultures derived from embryonic stem cells.

  2007cites this paper
• HRPAP20: a novel calmodulin-binding protein that increases breast cancer cell invasion

  2007cites this paper
• Expression of the human MTA1 gene in breast cell lines and in breast cancer tissues.

  2007cites this paper
• Matrix metalloproteinase-9, a potential biological marker in invasive pituitary adenomas

  2007cites this paper
• Matrix metalloproteinases and tumor metastasis

  2006cites this paper
• Antisense Ets-1 Transfection Restrains Oral Cancer Invasion by Reducing Matrix Metalloproteinase Activities

  2006cites this paper
• Targeting integrin-linked kinase inhibits Akt signaling pathways and decreases tumor progression of human glioblastoma

  2005cites this paper
• Differential expression of extracellular matrix remodeling genes in rat model of hemorrhagic shock and resuscitation.

  2005cites this paper
• Matrix metalloproteinase-9 secretion by human pituitary adenomas detected by cell immunoblot analysis

  2005cites this paper
• GnT-V, macrophage and cancer metastasis: A common link

  2004cites this paper
• Urinary Matrix Metalloproteinases and their Endogenous Inhibitors Predict Hepatic Regeneration after Murine Partial Hepatectomy

  2004cites this paper
• Antiangiogenic strategies, compounds, and early clinical results in breast cancer.

  2004cites this paper
• Regulation of MMP-9 (type IV collagenase) production and invasiveness in gliomas by the extracellular signal-regulated kinase and jun amino-terminal kinase signaling cascades

  2004cites this paper
• Direct cell-cell interaction enhances pro-MMP-2 production and activation in co-culture of laryngeal cancer cells and fibroblasts: involvement of EMMPRIN and MT1-MMP.

  2004cites this paper
• Protective Role of Lycopene Against Diethylnitrosamine Induced Experimental Hepatocarcinogenesis

  2004cites this paper
• A Randomized Phase II Feasibility Trial of BMS-275291 in Patients with Early Stage Breast Cancer

  2004cites this paper
• MMP-9 secretion and MMP-2 activation distinguish invasive and metastatic sublines of a mouse mammary carcinoma system showing epithelial-mesenchymal transition traits

  2004cites this paper
• Metalloproteinases and tissue inhibitors of metalloproteinases

  2004cites this paper
• Toward Checkmate: Biology and Breast Cancer Therapy for the New Millennium

  2004cites this paper
• EGF stimulates lamellipod extension in metastatic mammary adenocarcinoma cells by an actin-dependent mechanism

  2004cites this paper
• Matrix-degrading proteases in hormone-dependent breast cancer

  2004cites this paper
• Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes.

  2003cites this paper
• Genes Glioblastoma Invasion by Activating Invasion-enhancing Insulin-like Growth Factor Binding Protein 2 Enhances Updated

  2003cites this paper
• Angiopoietin-2 induces human glioma invasion through the activation of matrix metalloprotease-2

  2003cites this paper
• Role of MAP kinase in tumor progression and invasion

  2003cites this paper
• Advances in Brief Insulin-like Growth Factor Binding Protein 2 Enhances Glioblastoma Invasion by Activating Invasion-enhancing Genes 1

  2003cites this paper
• Angiogenesis in endocrine tumors.

  2003cites this paper
• Repression of 92-kDa Type IV Collagenase Expression by MTA1 Is Mediated through Direct Interactions with the Promoter via a Mechanism, Which Is Both Dependent on and Independent of Histone Deacetylation*

  2003cites this paper
• A randomized phase II pilot trial of adjuvant marimastat in patients with early-stage breast cancer.

  2002cites this paper
• Circulating 92‐kilodalton matrix metalloproteinase (MMP‐9) activity is enhanced in the euglobulin plasma fraction of head and neck squamous cell carcinoma

  2002cites this paper
• Detection of serum MMPs in tumor-bearing hamsters.

  2002cites this paper
• Implications of the Activation of Matrix Metalloproteinase-2 (MMP-2) on the Metastasis in Breast Cancer

  2002cites this paper
• FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway.

  2002cites this paper
• Adenovirus-mediated expression of antisense MMP-9 in glioma cells inhibits tumor growth and invasion

  2002cites this paper
• High expression of 92 kDa type IV collagenase (matrix metalloproteinase-9) in canine mammary adenocarcinoma.

  2001cites this paper
• Mechanisms of Bone Metastasis from Breast Cancer Using a Clinically Relevant Model

  2001cites this paper
• A case of tumor betrayal: biphasic effects of TIMP-1 on Burkitt's lymphoma.

  2001cites this paper
• Biphasic Effects of TIMP-1 on Burkitt’s Lymphoma

  2001cites this paper
• Multiple signaling pathways involved in activation of matrix metalloproteinase-9 (MMP-9) by heregulin-β1 in human breast cancer cells

  2001cites this paper
• Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN

  2001cites this paper
• Inhibition of aminopeptidase N (AP-N) and urokinase-type plasminogen activator (uPA) by zinc suppresses the invasion activity in human urological cancer cells.

  2001cites this paper
• The High Molecular Weight Urinary Matrix Metalloproteinase (MMP) Activity Is a Complex of Gelatinase B/MMP-9 and Neutrophil Gelatinase-associated Lipocalin (NGAL)

  2001cites this paper
• 大腸癌におけるMatrix Metalloproteinase-9, Sialyl LewisA, Lamininの発現と肝転移

  2000cites this paper
• Plasma metalloproteinase activity is enhanced in the euglobulin fraction of breast and lung cancer patients

  2000cites this paper
• Significance of serum type IV collagenolytic activities and gelatinase levels for detection of metastasis in murine RCT sarcoma.

  2000cites this paper
• Interleukin-1β Upregulates MMP-9 Expression in Stromal Cells of Human Giant Cell Tumor of Bone

  1999cites this paper
• Metalloproteinases and Stromal Biology in Cancer

  1999cites this paper
• Secretion of Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 by Meningiomas Detected by Cell Immunoblot Analysis

  1999cites this paper
• Matrix metalloproteinase 9 is induced by the Epstein–Barr virus BZLF1 transactivator

  1999cites this paper
• Therapeutic Effect of Clarithromycin on a Transplanted Tumor in Rats

  1999cites this paper
• Pancreatic Disease

  1999cites this paper
• Differential Modulatory Effects of Clarithromycin on the Production of Cytokines by a Tumor

  1999cites this paper
• Interleukin-1beta upregulates MMP-9 expression in stromal cells of human giant cell tumor of bone.

  1999cites this paper
• Therapeutic effect of a new synthetic lipid A analog (ONO-4007) on a tumor implanted at different sites in rats.

  1999cites this paper
• Matrix Metalloproteinases in the Pathogenesis of Breast Cancer

  1999cites this paper
• Metalloproteases and urokinase in angiogenesis and tumor progression.

  1998cites this paper
• ICAM-1 ImplicationLymphoma / Endothelial Cell Contact : Matrix Metalloproteinase-1 During T Metalloproteinase-9 and Tissue Inhibitor of Bi-Directional Induction of Matrix

  1998cites this paper
• Cancer cell heparanase activity associated with invasion and metastasis.

  1998cites this paper
• Bi-directional induction of matrix metalloproteinase-9 and tissue inhibitor of matrix metalloproteinase-1 during T lymphoma/endothelial cell contact: implication of ICAM-1.

  1998cites this paper
• ANALYSES OF PLASMA METALLOPROTEINASES AND TISSUE INHIBITOR OF METALLOPROTEINASES IN PATIENTS WITH BREAST CANCER

  1998cites this paper
• Induction of p53 Without Increase in p21WAF1 in Betulinic Acid-Mediated Cell Death Is Preferential for Human Metastatic Melanoma

  1998cites this paper
• Serum matrix metalloproteinase‐2 and its density in men with prostate cancer as a new predictor of disease extension

  1998cites this paper
• Increased incidence of matrix metalloproteinases in urine of cancer patients.

  1998cites this paper
• Membrane-type matrix metalloproteinase-1(MT1-MTP) gene is overexpressed in highly invasive hepatocellular carcinomas.

  1998cites this paper
• The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1.

  1998cites this paper
• Diuretic response to cyclophosphamide in rats bearing a matrix metalloproteinase-9-producing tumour.

  1998cites this paper
• CANCER C ELL H EPARANASE ACTIVITY A SSOCIATED W ITH INVASION A ND METASTASIS

  1998cites this paper
• Gelatinase B: Structure, Regulation, and Function

  1998cites this paper